A significant advance in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This crucial tumor suppressor protein is frequently inactivated in many kinds of malignancies, leading https://mysocialport.com/story7500379/vhh-fragments-reactivate-p53-a-potential-pathway-for-malignant-management